As a large number of multidrug-resistant bacteria have emerged, and there is an urgent need for the development of new antibacterial agents. In this study, we developed a liquid-based slow killing assay to be carried out in standard 96-well microtiter plates. This screening method was designed to facilitate highthroughput screening of small molecules and extracts. In antibiotic rescue assays, the Caenorhabditis elegans multidrug-resistant Pseudomonas aeruginosa infection model displayed a high degree of drug resistance in vivo and in vitro. We used the method to screen 1,300 extracts, and found 36 extracts (2.7%) which prolonged the survival of infected nematodes, and four (0.3%) of these extracts showed in vitro and in vivo anti-multidrug resistant P. aeruginosa activity. These results indicate that the whole-animal C. elegans multidrug-resistant bacterial model can be used to screen antibacterial compounds, and can also be useful for bioactive compounds which most likely cannot be identified in vitro.
Pseudomonas aeruginosa is recognized as one of the leading causes of severe hospital-acquired infections. Infections with P. aeruginosa are extremely difficult to eradicate due to the intrinsic resistance of this bacterium to a broad spectrum of antimicrobial agents and its repertoire of virulence factors. 1) More seriously, multidrug-resistant P. aeruginosa strains have been isolated with increasing frequency from clinical specimens worldwide.
2) Conventional anti-pseudomonal treatment includes elevated doses of -lactam, fluoroquinolone, or aminoglycoside antibiotics, 3) but these drugs possess high degrees of toxicity, and mucoid strains of P. aeruginosa are rarely eradicated by these treatments. 4) Therefore, one of the main objectives in drug development is to identify novel anti-infective drugs.
Caenorhabditis elegans is well established as a pertinent and practical model for studying host-pathogen interactions, 5, 6) bacterial virulence, [7] [8] [9] [10] innate immunity pathways, [11] [12] [13] and for screening novel antimicrobials. [14] [15] [16] The advantages of using a live animal model when screening for anti-infective compounds are that efficacy and toxicity can be tested concurrently. [17] [18] [19] Previous studies with C. elegans have indicated that depending on the growth medium, P. aeruginosa provokes different pathologies: slow-or fast-killing, lethal paralysis, and red death. 8, 10) We developed a highthroughput slow-killing assay using C. elegans as host, which was appropriate for the systematic screening of anti-infective extracts produced by endophytic fungi associated with medicinal plants. The discovery by Strobel, Stierle, and Hess that the endophytic fungus Taxomyces andreanae, isolated from Taxus brevifolia Nutt., produces the anti-cancer drug taxol 20) has significantly increased the study of endophytic fungi associated with medicinal plants, which may be an important source of new bioactive compounds. 21) Therefore, the two main objectives of this study were: (i) to develop a semi-automated, slow-killing, C. elegans-P. aeruginosa infective assay which can be used to screen extracts in vivo, and (ii) to use this new assay to identify bioactive endophytic fungal strains that produce secondary metabolites that prolong the survival of infected nematodes. Furthermore, we identified bioactive strains, and planned to separate and purify their bioactivity.
Materials and Methods
Bacterial isolates and nematode strains. P. aeruginosa strain A258 was obtained from Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, and P. aeruginosa strains PA-1, PA-2, PA-3, and ATCC 27853 were obtained from the First Hospital of Zhejiang, School of Medicine, Zhejiang University. Strains A258, PA-1, PA-2, and PA-3, isolated from clinical patients, were antibiotic-resistant. P. aeruginosa strains were maintained in 20% glycerin at À20 C until use. The antimicrobial susceptibility the parameters of antibioticresistant bacteria for various antibiotics are described in Table 1 .
glp-4(bn2ts);sek-1(km4) 16 ) is a double mutant strain. sek-1 mutants contain a mutation in a mitogen-activated protein kinase (MAPK) kinase (MAPKK) of the C. elegans innate immune p38 MAPK signaling cascade, and are more susceptible to a variety of pathogens. glp-4 temperature-sensitive sterile mutants do not make a germ line at 25 C, and survive without a bacterial food source. C. elegans was maintained on nematode growth medium (NGM) by standard practices.
22)
Screening of samples. The extracts from the SIPI (Shanghai Institute of Pharmaceutical Industry, Shanghai, China) Natural Products Repository are mainly secondary metabolites from endophytic fungi of medicinal plants (traditional chinese medicine, TCM). These medicinal plants include Alangium, Angelica sinensis, Bupleurum chinense, Herba plantaginis, Magnolia vine fruit, Herba methae, Stephania japonica, etc.
C. elegans agar medium killing assays. glp-4;sek-1 nematodes were synchronized by isolating eggs from gravid adults, hatching the eggs overnight in M9 buffer, 22) and plating L1-stage worms onto lawns of E. coli on NGM. The worms were grown to sterile young adults by incubation at 25 C for 48-52 h, washed off the plates with M9 buffer, resuspended, and washed in M9 buffer. Approximately 30 worms were deposited onto lawns of P. aeruginosa strains grown on peptoneglucose-sorbitol (PGS) agar 8) and nematode growth (NG) agar 8) plates containing kanamycin at 80 mg/mL to inhibit E. coli growth. The plates were incubated at 25 C and scored for worm survival at regular intervals.
C. elegans liquid medium killing and rescuing assays. Synchronized L4-stage to young adult glp-4;sek-1 nematodes were deposited onto lawns of the P. aeruginosa A258 strain grown on NG agar plates, and incubated for 20-24 h at 25 C. Infected worms were washed off the plates with M9 buffer, resuspended, and washed in M9 buffer. Some of the worms were resuspended in complete media (10% brain heart infusion, 80 mg/mL kanamycin, and 90% M9 buffer).
16) The other was resuspended in minimal media (M9 buffer). Approximately 25 worms in a volume of 100 mL were transferred to 96-well plates that contained equal volumes of antibiotics liquid or M9 buffer as control. To score for worm survival, the 96-well plates were placed under high light intensity, and the worms were considered dead if they did not move following stimulation by high light intensity or did not exhibit muscle tone.
Bacterial colonization. Bacterial colonization assay was performed as described previously. 16) A bacterial suspension was diluted and plated onto Luria-Bertani agar plates containing 80 mg/mL kanamycin to determine cfu. Each independent assay consisted of three replicates.
Screening of sample library in C. elegans. Synchronized worms were infected as described for the liquid killing assays. The infected worms were resuspended in M9 buffer. Approximately 25 worms in a volume of 100 mL were transferred into 96-well plates. Equal volumes of liquid containing the extracts to be tested were mixed into the wells. The final concentration of the extracts was 0.5-1 mg/mL with dimethyl sulfoxide at 1%.
Worm survival was scored manually after 1 and 10 d of incubation. A total of 1,300 extracts from the SIPI Natural Products Repository were screened. In the primary screening assay, screening of the 1,300 extracts was carried out in triplicate, and an extract was scored as a hit if the average survival rate of the worms was increased by 2-fold as compared with control, or if two of the triplicate wells showed a high level of rescue (approximately 80% rescue). The hit extracts were retested and scored as activities if the average survival rate was increased by 3-fold. A disc diffusion test was performed by using discs (d ¼ 6 mm) containing 20 mg of extracts and LB agar medium. When the zone diameter exceeded 12 mm, the extracts were considered to inhibit P. aeruginosa A258 in vitro. Bioactive endophytic fungal strains were identified by BLAST analysis of the 18S rRNA sequence.
Results

C. elegans multidrug-resistant P. aeruginosa infected killing assays
When glp-4;sek-1 nematodes were transferred from a lawn of E. coli, the organism's normal laboratory food, to lawns of P. aeruginosa growing on PGS or NG medium, the worms on the PGS medium were completely killed within 12 h (data not shown), but the worms on the NG medium died within a period of 5-7 d (Fig. 1) . When four strains of multidrug-resistant P. aeruginosa and sensitive strain P. aeruginosa ATCC 27853 were grown on high-osmolarity media (PGS), C. elegans killing occurred over the course of several h, and this was referred to as fast killing. In contrast, when these strains were grown on low-nutrient media (NG), C. elegans killing occurred over the course of several d, and this was referred to as slow killing. Fast killing is mediated at least in part by low-molecular-weight toxins, including phenazines, 23) whereas slow killing requires live bacteria and is correlated with the establishment and proliferation of P. aeruginosa in the C. elegans gut. 9) As shown in Fig. 1 , the kinetics of C. elegans slow killing by the four multidrug-resistant P. aeruginosa strains showed similar results (PA-A258 LT 50 ¼ 69 h, PA-1 LT 50 ¼ 79 h, PA-2 LT 50 ¼ 75 h, PA-3 LT 50 ¼ 85 h) (p > 0:01), and the slow-killing capabilities were not significantly different from sensitive P. aeruginosa ATCC 27853 (LT 50 ¼ 76:9 AE 5:5 h) (p > 0:01). Hence the P. aeruginosa A258 strain was chosen as the pathogenic bacterium to infect glp-4;sek-1 nematodes in the subsequent study.
C. elegans liquid medium killing and rescuing assays To develop a system that allows high-throughput screening of antibacterial compounds or extracts and to determine whether the liquid killing assay behaves in a way similar to the agar assay, we evaluated the effect of minimal media (M9 buffer) and complete media (90% M9 buffer þ 10% BHI) on nematode survival. As shown in Fig. 2 , when L4 stage glp-4;sek-1 nematodes were infected with P. aeruginosa A258 and transferred to complete media, they died with an LT 50 of less than 12 h, faster than the worms left in the minimal liquid medium (LT 50 % 6 d). Similarly to the agar assay, fast killing and slow killing were also observed in the liquid assay, but the infected worms lived longer in the minimal liquid medium than in the NG medium. Food for the worms was in short because the amounts of pathogenic bacteria were small in the minimal liquid medium. Longevity enhancement was induced in the minimal liquid medium by dietary restriction, 24) so the infected worms lived longer in the minimal liquid medium than in the NG medium. Infection persisted in the worms even after they were transferred to M9 buffer, in which P. aeruginosa A258 proliferated slowly (Fig. 3) and killed them. Hence, the minimal medium was chosen, for the C. elegans liquid medium rescuing and screening assays.
However, it was difficult to rescue the glp-4;sek-1 nematodes infected by P. aeruginosa A258, a multidrug-resistant strain with resistance to -lactams, aminoglycosides, and quinolones (Table 1) . Many antimicrobial agents were tested, and the results showed that these antimicrobial agents, with the exception of rifampicin (Rfp) and polymyxin B sulfate (Pbs), failed to cure the worms infected by P. aeruginosa A258 (e.g., tetracycline treatment, Fig. 4A ). As shown in Fig. 4B and C, incorporating rifampicin at 32 mg/mL or polymyxin B sulfate at 4 mg/mL into the M9 medium effectively rescued the infected worms, 80-90% of the worms surviving after 7 d. However, at a higher concentration, of 64 mg/mL, the beneficial effect of rifampicin was lost, and the nematodes died faster than those treated with 32 mg/mL rifampicin (Fig. 4B) . Toxicity was probably present at higher concentrations.
The effect of antibiotic treatment on the colonization of P. aeruginosa A258 in the nematode intestinal tract was also examined. After feeding on P. aeruginosa A258 for 24 h, an average of 7:4 Â 10 4 cfu was recovered from each worm (Fig. 5) . The worms were then transferred to liquid media containing 32 mg/mL of rifampicin, 4 mg/mL of polymyxin B sulfate, or 40 mg/mL of tetracycline. After 24 h of treatment, the numbers of cfu per worm in the rifampicin and polymyxin B sulfate-treated worms were only 1.5% and 16.1% of the number of cfu in the tetracyclinetreated worms respectively. After 5 d of treatment, the percentages dropped to 0.1% and 1.1% for the rifampicin and polymyxin B sulfate-treated worms respectively (Fig. 5) .
Screening of extracts to prevent killing of C. elegans by P. aeruginosa A258
We performed a pilot screen of anti-infective substances using a 96-well plate format with the C. elegans multidrug-resistant P. aeruginosa A258 liquid infection model. We examined the assay plates using a dissecting microscope at 1 and 10 d of incubation. After 10 d of incubation, approximately 80% of the untreated and 40 mg/mL tetracycline-treated worms died.
In the screening process, we observed the liquid states and death patterns of the worms, and found seven typical phenomena (Fig. 6) , each of which was chemically induced. As shown in Fig. 6A-1 , after the addition of the extracted samples to the well and incubation, the liquid remained transparent, but all the worms died with in 
Abbreviations: R, resistant; I, intermediate; S, susceptible A disc-diffusion test was done, and the results were interpreted according to Clinical and Laboratory Standards Institute (CLSI) methodology. 27, 28) 24 h. A possible cause is that the liquid medium contained toxic compounds from the screened extract, which rapidly killed the worms and bacteria. A-2 was similar to A-1. All the worms died within 24 h, but the liquid medium was turbid. The screened extracts contained insecticides which were able to cause the rapid death of the nematodes, but did not inhibit bacterial multiplication. As shown in Fig. 6B-1 , most of the infected worms died after 10 d of incubation, and the liquid medium remained transparent. A possible cause is that anti-infective compounds in the screened extracts inhibited or killed bacteria in vitro but not in vivo.
Another phenomenon (Fig. 6B-2 ) was similar to B-1, but bacterial growth turned the liquid medium turbid. This indicates that the well containing screened extracts did not exhibit activities. As Fig. 6C-1 and C-2 indicate, most of the infected worms survived after 10 d of incubation, and the liquid was either transparent or turbid. As shown in Fig. 6C-1 , the nematode survival ratio was highest because the anti-infective compounds in the screened well inhibited the bacteria in vitro and in vivo. As shown in Fig. 6C-2 , infected worms survived in the liquid medium following bacterial growth. This is consistent with previous reports. 16, 17) One reason might be that certain compounds reduced the toxicity of the pathogen. Another might be that these compounds enhanced the immune response of C. elegans to pathogen infection. We observed that the nematodes within the liquid medium containing extracts were induced a variety of phenotypes (Fig. 6D) . We are not sure why the worms shortened. We assume that the molecule is an antagonist, and reason that the small molecule interacted with amino acid residues within the target, disrupting biological functions. 25, 26) Primary screening identified 167 extracts (12.8% hit rate). Following secondary screening, 36 of these extracts (2.7%) were confirmed to promote the survival of the infected worms, and four extracts (0.3%) showed in vitro and in vivo anti-multidrug resistant P. aeruginosa activity. In the primary screening, 24 of the extracts (1.8%) caused the worms to display the characteristics in Fig. 6A-2 . Eleven of the extracts (0.8%) may have activated host immunity or attenuated pathogen virulence, resulting the worms displaying the characteristics in Fig. 6C-2 . Two of the extracts (0.1%) caused the worms to shorten and curl, as shown in Fig. 6D .
We identified four strains producing these extracts that showed activity against multidrug-resistant P. aer- A, Kaplan-Meier survival curves of infected nematodes treated with 5 mg/mL ( ), 20 mg/mL ( ), 40 mg/mL ( ), 80 mg/mL ( ), or no tetracycline (Tet) ( ). B, Kaplan-Meier survival curves of infected nematodes treated with 2 mg/mL ( , p ¼ 0:46), 8 mg/mL ( , p < 0:0001), 32 mg/mL ( , p < 0:0001), 64 mg/mL ( , p < 0:0001), or no rifampicin (Rfp) ( ). C, Kaplan-Meier survival curves of infected nematodes treated with 0.25 mg/mL ( , p ¼ 0:012), 1 mg/mL ( , p ¼ 0:68), 4 mg/mL ( , p < 0:0001), 16 mg/mL ( , p < 0:0001), or no polymyxin B sulfate (Pbs) ( ). Error bars equal SEM. P. aeruginosa A258-infected nematodes were treated in liquid media containing 32 mg/mL of rifampicin, 4 mg/mL of polymyxin B sulfate, or 40 mg/mL of tetracycline, and numbers of cfu per worm was determined. Error bars equal SEM.
uginosa in vitro and in vivo. Genus-specific identification by 18S rRNA amplification revealed that they were Alternaria sp. (SIPI 3.0127, from Angelica sinensis), Phoma exigua (SIPI 3.0266, from Alangium sp.), Alternaria sp. (SIPI 3.0444, from Herba plantaginis), and Aspergillus sydowii (SIPI 3.0451, from Plantago depressa).
Discussion
In China, TCM has been studied for thousands of years, and there are significant rich resources of medicinal plants. Currently, the study of endophytic pharmaceutical plants has become a focus of research. The present study focused on the screening of endophytic fungi associated with medicinal plants with antitumor and antibacterial activity. As a unique whole-animal host-pathogen model, C. elegans is simple and economical for studying evolutionarily conserved mechanisms of microbial pathogenesis and innate immunity, and is amenable to high-throughput techniques. We devised a multidrug-resistant bacterial infective model based on rescue of the nematode C. elegans to screen libraries of secondary metabolites of endophytic fungi for new bioactivities to treat multidrug-resistant P. aeruginosa infection. The next challenge is to purify these bioactive molecules and to identify the mechanisms of action for each of the compounds that promote worm survival.
